These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36571702)

  • 1. Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals.
    Berton M; Bettonte S; Stader F; Battegay M; Marzolini C
    Clin Pharmacokinet; 2023 Feb; 62(2):277-295. PubMed ID: 36571702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
    Ghobadi C; Johnson TN; Aarabi M; Almond LM; Allabi AC; Rowland-Yeo K; Jamei M; Rostami-Hodjegan A
    Clin Pharmacokinet; 2011 Dec; 50(12):809-22. PubMed ID: 22087867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models.
    Berton M; Bettonte S; Stader F; Battegay M; Marzolini C
    Clin Pharmacokinet; 2022 Sep; 61(9):1251-1270. PubMed ID: 35699913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly.
    Stader F; Kinvig H; Penny MA; Battegay M; Siccardi M; Marzolini C
    Clin Pharmacokinet; 2020 Mar; 59(3):383-401. PubMed ID: 31583609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs.
    Björkman S
    Br J Clin Pharmacol; 2005 Jun; 59(6):691-704. PubMed ID: 15948934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population.
    Abduljalil K; Pan X; Pansari A; Jamei M; Johnson TN
    Clin Pharmacokinet; 2020 Apr; 59(4):501-518. PubMed ID: 31587145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of physiologically based pharmacokinetic modeling to predict the pharmacokinetics of telavancin in obesity with renal impairment.
    Wu W; Ke M; Ye L; Lin C
    Eur J Clin Pharmacol; 2021 Jul; 77(7):989-998. PubMed ID: 33447912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Physiologically Based Pharmacokinetic Model for Itraconazole Pharmacokinetics and Drug-Drug Interaction Prediction.
    Chen Y; Ma F; Lu T; Budha N; Jin JY; Kenny JR; Wong H; Hop CE; Mao J
    Clin Pharmacokinet; 2016 Jun; 55(6):735-49. PubMed ID: 26692192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulation of differential drug pharmacokinetics under heat and exercise stress using a physiologically based pharmacokinetic modeling approach.
    Sidhu P; Peng HT; Cheung B; Edginton A
    Can J Physiol Pharmacol; 2011 May; 89(5):365-82. PubMed ID: 21627485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.
    Peters SA
    Clin Pharmacokinet; 2008; 47(4):261-75. PubMed ID: 18336055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration-Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics.
    Song L; Zhang Y; Jiang J; Ren S; Chen L; Liu D; Chen X; Hu P
    Clin Pharmacokinet; 2018 Oct; 57(10):1307-1323. PubMed ID: 29626326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy.
    Abduljalil K; Pansari A; Jamei M
    J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):361-383. PubMed ID: 32840724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
    Poulin P; Theil FP
    J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profiles.
    Peters SA
    Clin Pharmacokinet; 2008; 47(4):245-59. PubMed ID: 18336054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically based pharmacokinetic model of midazolam disposition during pregnancy.
    Andrew MA; Hebert MF; Vicini P
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():5454-7. PubMed ID: 19163951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.
    Watanabe A; Ishizuka T; Yamada M; Igawa Y; Shimizu T; Ishizuka H
    Eur J Clin Pharmacol; 2022 Jan; 78(1):65-73. PubMed ID: 34415382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4.
    Gaohua L; Abduljalil K; Jamei M; Johnson TN; Rostami-Hodjegan A
    Br J Clin Pharmacol; 2012 Nov; 74(5):873-85. PubMed ID: 22725721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midazolam Pharmacokinetics in Obese and Non-obese Children and Adolescents.
    Gade C; Sverrisdóttir E; Dalhoff K; Sonne J; Johansen MØ; Christensen HR; Burhenne J; Mikus G; Holm JC; Lund TM; Holst H
    Clin Pharmacokinet; 2020 May; 59(5):643-654. PubMed ID: 31745864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.
    Dallmann A; Ince I; Coboeken K; Eissing T; Hempel G
    Clin Pharmacokinet; 2018 Jun; 57(6):749-768. PubMed ID: 28924743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.